This contract involves the delivery of Prothrombin Complex Concentrate (PCC) to ensure continuous treatment for patients with prothrombin complex factor deficiencies. The PCC, classified as a prescription medication, will be supplied to designated recipients, specifically the Regional Blood Donation
Contract awarded. Originally published 10 months ago.
This contract involves the delivery of fibrinogen concentrate to ensure continuous treatment for patients suffering from fibrinogen deficiency, which is a blood clotting factor. The concentrate will be supplied to designated recipients, specifically the Regional Blood Donation and Blood Treatment Ce
This contract involves the production and delivery of promotional materials aimed at healthcare entities and diagnostic laboratories as part of educational initiatives. The required printed materials include: 510 posters, 18,900 patient leaflets, 5,200 staff leaflets, and 1,260 informational badges/
This contract involves the delivery of human coagulation factor VIII concentrate containing von Willebrand factor. The purpose is to ensure continuous treatment for patients with von Willebrand disease, with a required ratio of at least 1 unit of von Willebrand factor to 1 unit of factor VIII. Suppl
This contract involves the delivery of fibrinogen concentrate to ensure continuous treatment for patients suffering from fibrinogen deficiency, a crucial blood clotting factor. The concentrate will be supplied to designated Regional Blood Donation and Transfusion Centers (RCKiK) as specified by the
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
